Kobayashi Pharma Shareholders Reject Hong Kong Fund's Proposals
Osaka, Feb. 19 (Jiji Press)--Kobayashi Pharmaceutical Co. shareholders voted down proposals by Hong Kong-based investment fund Oasis Management Co. at their extraordinary meeting in Osaka on Wednesday.
Oasis, whose stake in the Japanese maker and seller of over-the-counter drugs and supplements tops 10 pct, proposed that lawyer Yoshio Nakamura and two others be appointed as outside board directors and that the high-profile health damage, including fatal cases, linked to "benikoji" red yeast supplements be reinvestigated under a more independent framework.
(2025/02/19-18:47)
To read a full story, please click here to find out how to subscribe.
BUSINESS
-
02/21 22:00 Nissan May Seek Investment from Tesla: FT -
02/21 10:56 Japanese Luxury Cruise Ship Asuka III to Enter into Service in July - 02/20 21:12 KKR Successfully Completes Tender Offer for Fuji Soft
- 02/20 18:28 (Update) Norinchukin Bank President to Resign over Huge Loss
- 02/20 16:45 Norinchukin Bank Projects Net Loss of 1.9 T. Yen
- 02/20 13:36 Suzuki Motor Targets Operating Profit of 800 B. Yen in FY 2030
- 02/20 09:38 Osaka Gas Aims to Boost City Gas Sales in India
- 02/19 19:32 Mitsui to Invest 5.3 B. Dlrs in Aussie Iron Ore Project
- 02/19 18:47 Kobayashi Pharma Shareholders Reject Hong Kong Fund's Proposals
- 02/19 15:47 Major Japanese Automakers Wary of Trump Tariffs
- 02/18 19:49 (Update) Mizuho Admits Safe Deposit Thefts Occurred in 2019
- 02/18 13:54 Safe Deposit Box Thefts Found at Mizuho Bank
- 02/17 23:01 JR Tokai Unveils Disney-Themed Shinkansen Train
- 02/17 19:53 (Update) Bain Capital Drops Bid for Fuji Soft
- 02/17 14:44 Bain Capital Drops Bid for Fuji Soft
- 02/15 13:07 Kioxia Posts Record Net Profit in April-Dec.
